Printer Friendly

Higher plasma vitamin D levels associated with lower biomarkers of cardiometabolic disease.

The United States Centers for Disease Control and Prevention (CDC) reports a reduction in risk factors for cardiometabolic disease among men and women with higher plasma vitamin D levels. *

Canadian researchers evaluated data from 1,928 men and women between the ages of 6 and 79 years who participated in the Canadian Health Measures Survey. Blood samples obtained during physical examinations were analyzed for glucose, fasting insulin, C-reactive protein, fibrinogen, homocysteine, triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A1, apolipoprotein B, and 25-hydroxyvitamin D [25(OH)D].

Vitamin D levels varied according to the month during which plasma levels were sampled. Subjects who had higher levels of vitamin D had reductions in insulin, insulin resistance, triglycerides, total cholesterol, LDL cholesterol, and ratio of total to HDL cholesterol.


Editor's Note: Cardiometabolic disease, also known as metabolic syndrome, is characterized by dyslipidemia, dysglycemia, abdominal obesity, and hypertension, which greatly increase the risk of cardiovascular disease and diabetes.

* Prev Chronic Dis. 2013 Jun 6;10:E91.

COPYRIGHT 2013 LE Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:IN THE NEWS
Author:Dye, D.
Publication:Life Extension
Article Type:Brief article
Geographic Code:1USA
Date:Sep 1, 2013
Previous Article:Research supports causative role for reduced vitamin D levels in high blood pressure.
Next Article:Cinnamon compounds may protect against tau protein aggregation in Alzheimer's Disease.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters